ADAP
Adaptimmune Therapeutics
ADAP
ADAP
77 hedge funds and large institutions have $195M invested in Adaptimmune Therapeutics in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 15 closing their positions.
Holders
77
Holders Change
-3
Holders Change %
-3.75%
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
16
Reduced
23
Closed
15
Calls
$219K
Puts
$70K
Net Calls
+$149K
Net Calls Change
+$257K